HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Upjohn preliminary injunction motion denied by federal court; generic minoxidil 2% shipping.

This article was originally published in The Rose Sheet

Executive Summary

BAUSCH & LOMB SHIPPING GENERIC MINOXIDIL 2% MAY 1, following Michigan federal court Judge Robert Holmes Bell's April 30 decision to "dissolve" the previously issued temporary restraining order that prohibited the generic manufacturer from marketing private label versions of Pharmacia & Upjohn's OTC Rogaine. Teva and Alpharma, the other companies to receive ANDA approval for the hair regrowth treatment, began shipping their products nationwide May 1. Alpharma had suspended shipments of its minoxidil topical solution 2% product on April 17.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel